Legal Representation
Attorney
Stacy L. Taylor
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 25, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 25, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 7, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 6, 2011 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 1, 2011 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 21, 2011 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 21, 2011 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 21, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 21, 2011 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 24, 2011 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 29, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 29, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 8, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 5, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 2, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 30, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biological tissue, namely, stem cells for scientific research use in the field of ophthamology, and reagents for research and manufacturing purposes, namely, cell culture reagents including but not limited to liquid and powdered media, frozen cells, cell growth factors, cell cytokines, and cell culture
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Biological tissue, namely, stem cells and tissues derived therefrom for use in treating ophthamlogical diseases, disorders and injuries
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Performing scientific and medical research for others, namely, evaluating potential therapeutic modalities for treating ophthalmological diseases, disorder and injuries using a stem-cell based research platform
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042